The addition of pembrolizumab to chemoradiotherapy improved survival outcomes for women with high-risk, locally advanced ...
The University of Pennsylvania has taken a novel approach to ensure that women with suspicious adnexal lesions are referred ...
Clinicians should adopt a risk-based, rather than biopsy-first, approach to encourage biopsy acceptance and improve early ...
In patients with a negative sentinel lymph node biopsy, omitting pelvic lymphadenectomy does not compromise disease-free ...
The Associated Press on MSN12d
Blood test for ovarian cancer misses some Black, Native American patients: StudyA new study finds that a common blood test for ovarian cancer may miss some Black and Native American patients, delaying ...
today announced updated clinical data from Part 1b of the ongoing DENALI clinical trial of azenosertib in patients with PROC in an oral presentation at the Society of Gynecologic Oncology (SGO) 2025 ...
today announced updated clinical data from Part 1b of the ongoing DENALI clinical trial of azenosertib in patients with PROC in an oral presentation at the Society of Gynecologic Oncology (SGO ...
Eleonora Teplinsky, MD, a medical oncologist specializing in breast and gynecologic cancers, has seen unregulated and ...
Results from the NRG Oncology GOG-0263 Phase III clinical trial testing the addition of cisplatin-based chemotherapy to adjuvant radiotherapy following radical hysterectomy and lymphadenectomy for ...
Toon Van Gorp, MD, PhD, a MIRASOL trial investigator, emphasizes that the final analysis reinforces the efficacy of mirvetuximab soravtansine-gynx (Elahere; AbbVie) in patients with folate receptor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback